339
Views
2
CrossRef citations to date
0
Altmetric
Review

Updated review of rescue treatments for seizure clusters and prolonged seizures

ORCID Icon & ORCID Icon
Pages 567-577 | Received 09 Apr 2022, Accepted 08 Jul 2022, Published online: 26 Jul 2022

References

  • Mitchell WG. Status epilepticus and acute repetitive seizures in children, adolescents, and young adults: etiology, outcome, and treatment. Epilepsia. 1996;37(Suppl s1):S74–80.
  • Haut SR. Seizure clusters: characteristics and treatment. Curr Opin Neurol. 2015 Apr;28(2):143–150.
  • Buelow JM, Shafer P, Shinnar R, et al. Perspectives on seizure clusters: gaps in lexicon, awareness, and treatment. Epilepsy Behav. 2016 Apr;57(Pt A):16–22.
  • Cereghino JJ. Identification and treatment of acute repetitive seizures in children and adults. Curr Treat Options Neurol. 2007 Jul;9(4):249–255.
  • Detyniecki K, O’Bryan J, Choezom T, et al. Prevalence and predictors of seizure clusters: a prospective observational study of adult patients with epilepsy. Epilepsy Behav. 2018 Nov;88:349–356.
  • Jafarpour S, Hirsch LJ, Gaínza-Lein M, et al. Seizure cluster: definition, prevalence, consequences, and management. Seizure. 2019 May;68:9–15.
  • Komaragiri A, Detyniecki K, Hirsch LJ. Seizure clusters: a common, understudied and undertreated phenomenon in refractory epilepsy. Epilepsy Behav. 2016 Jun;59:83–86.
  • Osorio I, Frei MG, Sornette D, et al. Pharmaco-resistant seizures: self-triggering capacity, scale-free properties and predictability? Eur J Neurosci. 2009 Oct;30(8):1554–1558.
  • Cook MJ, Varsavsky A, Himes D, et al. The dynamics of the epileptic brain reveal long-memory processes. Front Neurol. 2014;5:217.
  • Lim JA, Moon J, Kim TJ, et al. Clustering of spontaneous recurrent seizures separated by long seizure-free periods: an extended video-EEG monitoring study of a pilocarpine mouse model. PLoS One. 2018;13(3):e0194552.
  • Bauer J, Burr W. Course of chronic focal epilepsy resistant to anticonvulsant treatment. Seizure. 2001 Jun;10(4):239–246.
  • Haut SR, Lipton RB, LeValley AJ, et al. Identifying seizure clusters in patients with epilepsy. Neurology. 2005 Oct 25 65(8):1313–1315.
  • Martinez C, Sullivan T, Hauser WA. Prevalence of acute repetitive seizures (ARS) in the United Kingdom. Epilepsy Res. 2009 Dec;87(2–3):137–143.
  • Chen B, Choi H, Hirsch LJ, et al. Prevalence and risk factors of seizure clusters in adult patients with epilepsy. Epilepsy Res. 2017 Jul;133:98–102.
  • Fisher RS, Bartfeld E, Cramer JA. Use of an online epilepsy diary to characterize repetitive seizures. Epilepsy Behav. 2015 Jun;47:66–71.
  • Sillanpää M, Schmidt D. Seizure clustering during drug treatment affects seizure outcome and mortality of childhood-onset epilepsy. Brain. 2008 Apr;131(Pt 4):938–944.
  • Haut SR, Shinnar S, Moshé SL. Seizure clustering: risks and outcomes. Epilepsia. 2005 Jan;46(1):146–149.
  • Asadi-Pooya AA, Nei M, Sharan A, et al. Seizure clusters in drug-resistant focal epilepsy. Epilepsia. 2016 Sep;57(9):e187–90.
  • Sinha S, Satishchandra P, Kalband BR, et al. New-onset status epilepticus and cluster seizures in the elderly. J Clin Neurosci. 2013 Mar;20(3):423–428.
  • Penovich PE, Buelow J, Steinberg K, et al. Burden of seizure clusters on patients with epilepsy and caregivers: survey of patient, caregiver, and clinician perspectives. Neurologist. 2017 Nov;22(6):207–214.
  • Chung S, Szaflarski JP, Choi EJ, et al. A systematic review of seizure clusters: prevalence, risk factors, burden of disease and treatment patterns. Epilepsy Res. 2021 Nov;177:106748.
  • Tan M, Boston R, Cook MJ, et al. Risk factors for injury in a community-treated cohort of patients with epilepsy in Australia. Epilepsia. 2019 Mar;60(3):518–526.
  • Gidal B, Klein P, Hirsch LJ. Seizure clusters, rescue treatments, seizure action plans: unmet needs and emerging formulations. Epilepsy Behav. 2020 Nov;112:107391.
  • Trinka E, Cock H, Hesdorffer D, et al. A definition and classification of status epilepticus–Report of the ILAE task force on classification of status epilepticus. Epilepsia. 2015 Oct;56(10):1515–1523.
  • Glauser T, Shinnar S, Gloss D, et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American Epilepsy Society. Epilepsy Curr. 2016 Jan-Feb;16(1):48–61.
  • Silbergleit R, Durkalski V, Lowenstein D, et al. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med. 2012 Feb 16 366(7):591–600.
  • Gaínza-Lein M, Sánchez Fernández I, Jackson M, et al. Association of time to treatment with short-term outcomes for pediatric patients with refractory convulsive status epilepticus. JAMA Neurol. 2018 Apr 1;75(4):410–418.
  • Alldredge BK, Gelb AM, Isaacs SM, et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med. 2001 Aug 30 345(9):631–637.
  • Maglalang PD, Rautiola D, Siegel RA, et al. Rescue therapies for seizure emergencies: new modes of administration. Epilepsia. 2018 Oct;59(Suppl 2):207–215.
  • Gaínza-Lein M, Benjamin R, Stredny C, et al. Rescue medications in epilepsy patients: a family perspective. Seizure. 2017 Nov;52:188–194.
  • Dreifuss FE, Rosman NP, Cloyd JC, et al. A comparison of rectal diazepam gel and placebo for acute repetitive seizures. N Engl J Med. 1998 Jun 25 338(26):1869–1875.
  • Kriel RL, Cloyd JC, Pellock JM, et al. Rectal diazepam gel for treatment of acute repetitive seizures. The North American Diastat Study Group. Pediatr Neurol. 1999 Apr;20(4):282–288.
  • Cereghino JJ, Cloyd JC, Kuzniecky RI. Rectal diazepam gel for treatment of acute repetitive seizures in adults. Arch Neurol. 2002 Dec;59(12):1915–1920.
  • Arya R, Kothari H, Zhang Z, et al. Efficacy of nonvenous medications for acute convulsive seizures: a network meta-analysis. Neurology. 2015 Nov 24 85(21):1859–1868.
  • Haut SR, Seinfeld S, Pellock J. Benzodiazepine use in seizure emergencies: a systematic review. Epilepsy Behav. 2016 Oct;63:109–117.
  • Bhattacharyya M, Kalra V, Gulati S. *Intranasal midazolam vs rectal diazepam in acute childhood seizures. Pediatr Neurol. 2006 May;34(5):355–359.
  • Fişgin T, Gurer Y, Teziç T, et al. Effects of intranasal midazolam and rectal diazepam on acute convulsions in children: prospective randomized study. J Child Neurol. 2002 Feb;17(2):123–126.
  • de Haan GJ, van der Geest P, Doelman G, et al. A comparison of midazolam nasal spray and diazepam rectal solution for the residential treatment of seizure exacerbations. Epilepsia. 2010 Mar;51(3):478–482.
  • Holsti M, Dudley N, Schunk J, et al. Intranasal midazolam vs rectal diazepam for the home treatment of acute seizures in pediatric patients with epilepsy. Arch Pediatr Adolesc Med. 2010 Aug;164(8):747–753.
  • Harbord MG, Kyrkou NE, Kyrkou MR, et al. Use of intranasal midazolam to treat acute seizures in paediatric community settings. J Paediatr Child Health. 2004 Sep-Oct;40(9–10):556–558.
  • Detyniecki K, Van Ess PJ, Sequeira DJ, et al. Safety and efficacy of midazolam nasal spray in the outpatient treatment of patients with seizure clusters-a randomized, double-blind, placebo-controlled trial. Epilepsia. 2019 Sep;60(9):1797–1808.
  • Wheless JW, Meng TC, Van Ess PJ, et al. Safety and efficacy of midazolam nasal spray in the outpatient treatment of patients with seizure clusters: an open-label extension trial. Epilepsia. 2019 Sep;60(9):1809–1819.
  • Owusu KA, Dhakar MB, Bautista C, et al. Comparison of intranasal midazolam versus intravenous lorazepam for seizure termination and prevention of seizure clusters in the adult epilepsy monitoring unit. Epilepsy Behav. 2019 Sep;98(Pt A):161–167.
  • von Blomberg A, Kay L, Knake S, et al. Efficacy, tolerability, and safety of concentrated intranasal midazolam spray as emergency medication in epilepsy patients during video-EEG monitoring. CNS Drugs. 2020 May;34(5):545–553.
  • Kay L, Merkel N, von Blomberg A, et al. Intranasal midazolam as first-line in hospital treatment for status epilepticus: a pharmaco-EEG cohort study. Ann Clin Transl Neurol. 2019 Dec;6(12):2413–2425.
  • Hogan RE, Gidal BE, Koplowitz B, et al. Bioavailability and safety of diazepam intranasal solution compared to oral and rectal diazepam in healthy volunteers. Epilepsia. 2020 Mar;61(3):455–464.
  • Hogan RE, Tarquinio D, Sperling MR, et al. Pharmacokinetics and safety of VALTOCO (NRL-1; diazepam nasal spray) in patients with epilepsy during seizure (ictal/peri-ictal) and nonseizure (interictal) conditions: a phase 1, open-label study. Epilepsia. 2020 May;61(5):935–943.
  • Wheless JW, Miller I, Hogan RE, et al. Final results from a Phase 3, long-term, open-label, repeat-dose safety study of diazepam nasal spray for seizure clusters in patients with epilepsy. Epilepsia. 2021 Oct;62(10):2485–2495.
  • Klimach VJ. The community use of rescue medication for prolonged epileptic seizures in children. Seizure. 2009 Jun;18(5):343–346.
  • Nakken KO, Lossius MI. Buccal midazolam or rectal diazepam for treatment of residential adult patients with serial seizures or status epilepticus. Acta Neurol Scand. 2011 Aug;124(2):99–103.
  • Baysun S, Aydin OF, Atmaca E, et al. A comparison of buccal midazolam and rectal diazepam for the acute treatment of seizures. Clin Pediatr (Phila). 2005 Nov-Dec;44(9):771–776.
  • Ashrafi MR, Khosroshahi N, Karimi P, et al. Efficacy and usability of buccal midazolam in controlling acute prolonged convulsive seizures in children. Eur J Paediatr Neurol. 2010 Sep;14(5):434–438.
  • Scott RC, Besag FM, Neville BG. Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: a randomised trial. Lancet. 1999 Feb 20; 353(9153):623–626.
  • Talukdar B, Chakrabarty B. Efficacy of buccal midazolam compared to intravenous diazepam in controlling convulsions in children: a randomized controlled trial. Brain Dev. 2009 Nov;31(10):744–749.
  • McIntyre J, Robertson S, Norris E, et al. Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial. Lancet. 2005 Jul 16-22 366(9481):205–210.
  • Mpimbaza A, Ndeezi G, Staedke S, et al. Comparison of buccal midazolam with rectal diazepam in the treatment of prolonged seizures in Ugandan children: a randomized clinical trial. Pediatrics. 2008 Jan;121(1):e58–64.
  • Yoshinaga H, Benitez A, Takeda S, et al. A Phase 3 open-label study of the efficacy, safety and pharmacokinetics of buccally administered midazolam hydrochloride for the treatment of status epilepticus in pediatric Japanese subjects. Epilepsy Res. 2021 Aug;174:106651.
  • Shankar R, Goodwin M, Toland J, et al. Oro-mucosal midazolam maleate: use and effectiveness in adults with epilepsy in the UK. Epilepsy Behav. 2021 Oct;123:108242.
  • Abou-Khalil B, Wheless J, Rogin J, et al. A double-blind, randomized, placebo-controlled trial of a diazepam auto-injector administered by caregivers to patients with epilepsy who require intermittent intervention for acute repetitive seizures. Epilepsia. 2013 Nov;54(11):1968–1976.
  • Rogin J, Wheless J, Abou-Khalil B, et al. Safety and effectiveness of long-term treatment with diazepam auto-injector administered by caregivers in an outpatient setting for the treatment of acute repetitive seizures. Epilepsia. 2014 Sep;55(9):1444–1451.
  • Rogawski MA, Heller AH. Diazepam buccal film for the treatment of acute seizures. Epilepsy Behav. 2019 Dec;101(Pt B):106537.
  • Seinfeld S, Gelfand MA, Heller AH, et al. Safety and tolerability associated with chronic intermittent use of diazepam buccal film in adult, adolescent, and pediatric patients with epilepsy. Epilepsia. 2020 Nov;61(11):2426–2434.
  • French JA, Wechsler R, Gelfand MA, et al. Inhaled alprazolam rapidly suppresses epileptic activity in photosensitive participants. Epilepsia. 2019 Aug;60(8):1602–1609.
  • Fisher RS, Eggleston KS, Wright CW. Vagus nerve stimulation magnet activation for seizures: a critical review. Acta Neurol Scand. 2015 Jan;131(1):1–8.
  • Boon P, Vonck K, Van Walleghem P, et al. Programmed and magnet-induced vagus nerve stimulation for refractory epilepsy. J Clin Neurophysiol. 2001 Sep;185:402–407. official publication of the American Electroencephalographic Society.
  • Morris GL. 3rd. A retrospective analysis of the effects of magnet-activated stimulation in conjunction with vagus nerve stimulation therapy. Epilepsy Behav. 2003 Dec;4(6):740–745.
  • Ben-Menachem E, Mañon-Espaillat R, Ristanovic R, et al. Vagus nerve stimulation for treatment of partial seizures: 1. A controlled study of effect on seizures. first international vagus nerve stimulation study group. Epilepsia. 1994 May-Jun;35(3):616–626.
  • Quraishi IH, Hirsch LJ. Patient-detectable responsive neurostimulation as a seizure warning system. Epilepsia. 2021 Jul;62(7):e110–e116.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.